What is Hypochondroplasia

Hypochondroplasia is a genetic skeletal dysplasia characterized by short-limbed short stature that is generally milder than that seen in achondroplasia. It is caused by mutations in the FGFR3 gene, which disrupt normal bone growth and development during childhood and adolescence.

What are the primary clinical features of Hypochondroplasia?

Individuals with Hypochondroplasia typically present with disproportionate short stature, where the limbs are shorter in relation to the trunk. While the physical features are often subtle at birth, the condition becomes more apparent as growth slows during early childhood. Common clinical findings include:

• Mild shortening of the humerus and femur bones.


• Macrocephaly (a larger-than-average head size) that is less pronounced than in other dysplasias.


• Limited range of motion at the elbows.


• Lumbar lordosis (an inward curvature of the lower spine).


• Occasional cognitive or behavioral delays, though most individuals have normal intelligence.

What causes Hypochondroplasia and is it hereditary?

Hypochondroplasia is caused by a mutation in the FGFR3 gene, which provides instructions for making a protein involved in bone development. The condition follows an autosomal dominant inheritance pattern. This means that if a parent has Hypochondroplasia, there is a 50% chance of passing the mutation to each child. However, many cases occur as a result of a *de novo* (new) mutation in an individual with no family history of the condition.

How does Hypochondroplasia differ from other skeletal dysplasias?

Hypochondroplasia is frequently compared to achondroplasia because both involve the same gene. However, Hypochondroplasia is clinically distinct due to its more moderate impact on bone growth. Unlike achondroplasia, individuals with Hypochondroplasia rarely exhibit the characteristic mid-face hypoplasia or significant spinal stenosis early in life, making the diagnosis often delayed until a child fails to meet expected growth milestones.

What is the prevalence of this condition?

Precise global prevalence is difficult to determine, but Hypochondroplasia is estimated to affect approximately 1 in 15,000 to 1 in 40,000 individuals. Within the DiseaseMaps community, 22 people with Hypochondroplasia have shared their experiences, highlighting the importance of connecting with others who understand the unique journey of living with a rare skeletal dysplasia.

Next steps

• Consult a clinical geneticist for formal diagnosis and family planning counseling.


• Schedule regular evaluations with a pediatric endocrinologist to monitor growth patterns.


• Join the DiseaseMaps.org community to connect with other families living with Hypochondroplasia.


• Request a referral to an orthopedic specialist if you experience joint pain or mobility limitations.

Medical disclaimer: This content is for informational purposes only and does not substitute professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Hypochondroplasia overview.


• Orphanet: Rare disease database entry for Hypochondroplasia (ORPHA:404).


• OMIM (Online Mendelian Inheritance in Man): #146000 Hypochondroplasia.


• Little People of America (LPA): Resources for skeletal dysplasias.